PULMATRIX, INC. Accrued Liabilities, Current
PULMATRIX, INC. (PULM) had Accrued Liabilities, Current of $2.75 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2022-11-10
- 2022-09-30: Accrued Liabilities, Current $2.75M.
- 2022-06-30: Accrued Liabilities, Current $1.61M.
- 2022-03-31: Accrued Liabilities, Current $1.07M.
- 2021-12-31: Accrued Liabilities, Current $1.23M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2022-09-30 | $2.75M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.61M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $1.07M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.23M 10-Q · filed 2022-11-10 |
| 2021-09-30 | $1.39M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.19M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $1.87M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.03M 10-K · filed 2022-03-29 |
| 2020-09-30 | $2.39M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $3.44M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $3.55M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $2.51M 10-K · filed 2021-03-23 |
| 2019-09-30 | $1.26M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $1.23M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $2.18M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $1.70M 10-K · filed 2020-03-26 |
| 2018-09-30 | $2.28M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.27M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $2.48M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $2.16M 10-K · filed 2019-02-19 |
| 2017-09-30 | $1.59M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $2.58M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $1.44M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $1.32M 10-K · filed 2018-03-13 |
| 2016-09-30 | $1.19M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $1.21M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $1.06M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $1.49M 10-K · filed 2017-03-10 |
| 2015-09-30 | $1.14M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $1.01M 10-Q · filed 2015-08-14 |
| 2014-12-31 | $3.54M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |